Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
22 May 2023 |
Main ID: |
NCT02751138 |
Date of registration:
|
19/04/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Determination of Immune Phenotype in Glioblastoma Patients
|
Scientific title:
|
Determination of Immune Phenotype in Glioblastoma Patients |
Date of first enrolment:
|
March 1, 2016 |
Target sample size:
|
100 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02751138 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Germany
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- adult glioblastoma multiforme
Exclusion Criteria:
- pregnancy, unable to give consent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Glioblastoma Multiforme
|
Intervention(s)
|
Procedure: Surgery
|
Primary Outcome(s)
|
Overall survival
[Time Frame: 3 months]
|
Secondary Outcome(s)
|
Karnofsky performance score
[Time Frame: 3 months]
|
Progression free survival
[Time Frame: 3 months]
|
Secondary ID(s)
|
University Hospital Ulm
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|